Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients | Zendy

Liesbeth Viaene | Zendy; Bert Bammens | Zendy; Björn Meijers | Zendy; Yves Vanrenterghem | Zendy; Dirk Vanderschueren | Zendy; Pieter Evenepoel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients

Author(s) -

Liesbeth Viaene,

Bert Bammens,

Björn Meijers,

Yves Vanrenterghem,

Dirk Vanderschueren,

Pieter Evenepoel

Publication year - 2011

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfr596

Subject(s) - fibroblast growth factor 23 , medicine , endocrinology , renal function , dialysis , hemodialysis , cohort , vitamin d and neurology , peritoneal dialysis , urology , parathyroid hormone , calcium

Both poor residual renal function (RRF) and high fibroblast growth factor 23 (FGF-23) levels are associated with arterial stiffness, left ventricular hypertrophy and increased (cardiovascular) mortality. Whether FGF-23 and RRF are interrelated is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research